Form D — Silo Pharma, Inc.
0001213900-26-077974 · filed Jul 14, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $4,000,015
- Reported amount sold
- $4,000,015
- Minimum investment
- $0
- Investors
- 4
- Sales commission
- $300,002
- Finders' fees
- $0
Issuer
- Name
- Silo Pharma, Inc.
- CIK
- 1514183
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- —
- Address
- 677 N. WASHINGTON BOULEVARD
SARASOTA, FL 34236 - Phone
- (718) 400-9031
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Eric Weisblum · Executive OfficerSARASOTA, FL Find on LinkedIn ↗
-
Daniel Ryweck · Executive OfficerSARASOTA, FL Find on LinkedIn ↗
-
Wayne Linsley · DirectorSARASOTA, FL Find on LinkedIn ↗
-
Kevin Munoz · DirectorSARASOTA, FL Find on LinkedIn ↗
-
Jeff Pavell · DirectorSARASOTA, FL Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗